Sex-specific considerations in nanomedicine: highlighting the impact of the menstrual cycle on drug development

Abstract

Tweetable abstract The female menstrual cycle is one of the most overlooked sex-specific factors in drug distribution and response. Unlocking the potential of nanomedicine demands a fundamental understanding of the impact biological sex has on drug distribution, efficacy and adverse effects.

Keywords: clinical trials; drug development; hormonal changes; menstrual cycle; nanomedicine; nanoparticles; protein corona; sex differences; sex-specific analysis; women's health.